Semaglutide

Clinical trials show average weight loss of 15-17% of body weight over 68 weeks. This means someone weighing 200 lbs could expect to lose 30-34 lbs on average. However, individual results vary significantly, some people lose more, some less. About one-third of participants in trials lost more than 20% of their body weight. Results depend heavily on dose, diet, exercise, and individual biology.

Most people notice reduced appetite within the first 1-2 weeks of starting semaglutide. However, significant weight loss typically becomes visible after 4-8 weeks as you titrate up to therapeutic doses. The starting dose (0.25mg) is sub-therapeutic and meant for adjustment. Full effects are usually seen at doses of 1.0mg or higher, which takes about 8-12 weeks to reach with proper titration.

The most common side effects are gastrointestinal: nausea (affecting 30-40% of users), diarrhea, vomiting, and constipation. These typically improve after 4-8 weeks as your body adjusts. Other side effects include headache, fatigue, and injection site reactions. Serious but rare side effects include pancreatitis (severe abdominal pain), gallbladder problems, and thyroid tumors (seen in rodent studies, unclear risk in humans).

Light to moderate alcohol consumption is generally considered safe with semaglutide, but many users report reduced alcohol tolerance. Because semaglutide slows gastric emptying, alcohol may be absorbed differently and feel stronger. Additionally, alcohol is high in empty calories that can undermine weight loss goals. Heavy drinking increases the risk of pancreatitis, which is already a rare risk with semaglutide.

If you miss a dose, take it as soon as you remember, as long as it's within 5 days of the missed dose. Then resume your regular weekly schedule. If more than 5 days have passed, skip the missed dose and take your next scheduled dose. Never double up on doses. Setting a weekly reminder on the same day helps prevent missed doses.

Semaglutide is the active ingredient in both Ozempic and Wegovy. Ozempic is approved for type 2 diabetes (doses up to 2.0mg), while Wegovy is approved for weight loss (doses up to 2.4mg). The molecule is identical, the difference is the approved indication and maximum dose. Some people use Ozempic off-label for weight loss due to better insurance coverage or availability.

Most people regain a significant portion of lost weight after stopping semaglutide. Studies show about two-thirds of weight is typically regained within one year of discontinuation. This is because semaglutide addresses appetite and metabolic factors that don't change permanently. Many physicians view GLP-1 medications as long-term or indefinite therapy for weight management, similar to blood pressure medication.

Muscle loss is a real concern, studies show about 25-40% of weight lost on semaglutide can be lean mass. To minimize this: eat at least 0.7-1g of protein per pound of goal body weight daily, prioritize protein at every meal (eat it first), perform resistance training 2-3 times per week, and ensure adequate total calorie intake (avoid overly aggressive deficits). Some clinicians also recommend creatine supplementation.